Article Information
History
- February 10, 2023.
Article Versions
- You are currently viewing Version 1 of this article (February 10, 2023 - 16:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Nima Taefehshokr1,
- Alex Lac1,
- Angela M Vrieze1,
- Brandon H Dickson1,
- Peter N Guo1,
- Catherine Jung1,
- Eoin N Blythe1,2,
- Corby Fink1,2,
- Gregory A Dekaban1,2 and
- Bryan Heit1,2,*
- 1Department of Microbiology and Immunology, and the Western Infection, Immunity and Inflammation Centre, The University of Western Ontario, London, Ontario, Canada, N6A 5C1
- 2Robarts Research Institute, London, Ontario, Canada, N6A 3K7
- ↵*Corresponding Author: bheit{at}uwo.ca
Posted February 10, 2023.
SARS-CoV-2 NSP5 Antagonizes the MHC II Antigen Presentation Pathway by Hijacking Histone Deacetylase 2
